These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33822421)

  • 1. Silibinin as potential tool against SARS-Cov-2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects.
    Speciale A; Muscarà C; Molonia MS; Cimino F; Saija A; Giofrè SV
    Phytother Res; 2021 Aug; 35(8):4616-4625. PubMed ID: 33822421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2.
    Hamdy R; Mostafa A; Abo Shama NM; Soliman SSM; Fayed B
    Phytother Res; 2022 Jul; 36(7):2921-2939. PubMed ID: 35596627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective.
    Abosheasha MA; El-Gowily AH; Elfiky AA
    J Thromb Thrombolysis; 2022 Feb; 53(2):273-281. PubMed ID: 34510337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Rout J; Swain BC; Tripathy U
    J Biomol Struct Dyn; 2022 Feb; 40(2):860-874. PubMed ID: 32938313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico evaluation of food-derived carotenoids against SARS-CoV-2 drug targets: Crocin is a promising dietary supplement candidate for COVID-19.
    Mujwar S; Sun L; Fidan O
    J Food Biochem; 2022 Sep; 46(9):e14219. PubMed ID: 35545850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 Through a Molecular Docking Study.
    Mondal M; Sarkar C; Jamaddar S; Khalipha ABR; Islam MT; Mahafzah A; Mubarak MS
    Infect Disord Drug Targets; 2021; 21(7):e160921188777. PubMed ID: 33292147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
    Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
    Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Prasanth DSNBK; Murahari M; Chandramohan V; Panda SP; Atmakuri LR; Guntupalli C
    J Biomol Struct Dyn; 2021 Aug; 39(13):4618-4632. PubMed ID: 32567989
    [No Abstract]   [Full Text] [Related]  

  • 10. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
    Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
    Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico study of the potential interactions of 4'-acetamidechalcones with protein targets in SARS-CoV-2.
    Q Almeida-Neto FW; Castro Matos MG; Marinho EM; Marinho MM; Róseo Paula Pessoa Bezerra de Menezes R; Sampaio TL; Bandeira PN; Celedonio Fernandes CF; Magno Rodrigues Teixeira A; Marinho ES; de Lima-Neto P; Silva Dos Santos H
    Biochem Biophys Res Commun; 2021 Jan; 537():71-77. PubMed ID: 33387885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silybin B and Cianidanol Inhibit M
    Srivastava R; Tripathi S; Unni S; Hussain A; Haque S; Dasgupta N; Singh V; Mishra BN
    Curr Pharm Des; 2021; 27(32):3476-3489. PubMed ID: 33302853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechin Derivatives as Inhibitor of COVID-19 Main Protease (Mpro): Molecular Docking Studies Unveil an Opportunity Against CORONA.
    Arif MN
    Comb Chem High Throughput Screen; 2022; 25(1):197-203. PubMed ID: 33231155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of nut protein-derived peptides against SARS-CoV-2 spike protein and main protease.
    Zhao W; Xu G; Yu Z; Li J; Liu J
    Comput Biol Med; 2021 Nov; 138():104937. PubMed ID: 34655899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an
    Mahanta S; Chowdhury P; Gogoi N; Goswami N; Borah D; Kumar R; Chetia D; Borah P; Buragohain AK; Gogoi B
    J Biomol Struct Dyn; 2021 Jul; 39(10):3802-3811. PubMed ID: 32406317
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcal proteases exhibit the potential to activate the latent SARS-CoV-2 spike protein.
    Mjokane N; Sabiu S; Folorunso OS; Gcilitshana OMN; Albertyn J; Pohl CH; Sebolai OM
    J Infect Public Health; 2024 Feb; 17(2):263-270. PubMed ID: 38128410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.